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Mammalian odorant receptors (ORs) are crucial
for establishing the functional organization
of the olfactory system, but the mechanisms
controlling their expression remain largely un-
explained. Here, we utilized a transgenic
approach to explore OR gene regulation. We
determined that although olfactory sensory
neurons (OSNs) are capable of supporting ex-
pression of multiple functional ORs, several
levels of control ensure that each neuron nor-
mally expresses only a single odorant receptor.
Surprisingly, this regulation extends beyond
endogenous ORs even preventing expression
of transgenes consisting of OR-coding se-
quences driven by synthetic promoters. Thus,
part of the intrinsic feedback system must rely
on elements present in the OR-coding se-
quence. Notably, by expressing the same trans-
genic ORs precociously in immature neurons,
we have overcome this suppression and estab-
lished a generic method to express any OR in
90% of OSNs. These results provide impor-
tant insights into the hierarchy of OR gene ex-
pression and the vital role of the OR-coding se-
quence in this regulation.
INTRODUCTION
The mammalian sense of smell relies on the detection of
odorants by a very large family of G protein coupled re-
ceptors (GPCRs), which, in mice, are encoded by approx-
imately 1300 different genes (Buck and Axel, 1991; Zhang
et al., 2007). These odorant receptors (ORs) are expressed
by olfactory sensory neurons (OSNs) residing deep within
the nasal cavities in themain olfactory epithelium (MOE). A
key feature of the mammalian olfactory system is that
each OSN expresses just one of the 2600 potential OR al-
leles (Chess et al., 1994; Malnic et al., 1999). This estab-
lishes the odorant selectivity of the neuron and marks itsCell 1identity with that of a single specific OR protein. ORs
also play an instructive role in the central projection of
OSNs (Ressler et al., 1994; Vassar et al., 1994;Mombaerts
et al., 1996; Wang et al., 1998) and the generation of
a topographic map of odorant response properties in the
olfactory bulb (Malnic et al., 1999; Belluscio and Katz,
2001). Thus, precise control of OR gene expression is fun-
damental for the assembly and operation of the mamma-
lian olfactory system.
How does an OSN select a single OR allele from this
large gene family for expression? Over the past few years
two important principles have emerged. First, short DNA
sequences upstream of the OR transcriptional start site
have been demonstrated to have the capacity to drive
the expression of ORs and reporter genes in OSNs in pat-
terns that resemble those of endogenous ORs (Qasba and
Reed, 1998; Vassalli et al., 2002). Second, OR gene ex-
pression prevents activation of other endogenous OR
genes by utilizing an OR protein-dependent feedback
mechanism (Serizawa et al., 2003; Lewcock and Reed,
2004; Shykind et al., 2004). Recently, it was proposed
that a putative transactivating element (H) may be involved
in initiating expression of a single OR (Lomvardas et al.,
2006). In this model, the unique complex containing the
H element would also serve as a target for feedback
mechanisms that recognize the expression of a functional
OR protein, thus preventing activation of additional OR al-
leles (Serizawa et al., 2003; Lewcock and Reed, 2004;
Shykind et al., 2004). However, more recent evidence
demonstrates that the H region is not essential for expres-
sion of most ORs but rather functions in cis, much like
the locus control region (LCR) of the globin gene cluster,
controlling the expression of a local group of OR genes
(Serizawa et al., 2000, 2003; Fuss et al., 2007). Conse-
quently, it was proposed that there may be many such
LCR-like elements in the genome (Serizawa et al., 2004;
Fuss et al., 2007). While these studies provide useful infor-
mation to help explain how a single OR might be chosen,
many aspects of OR gene regulation still remain unclear.
Here, we have used a new approach to broadly express
single ORs in many OSNs and have uncovered the pres-
ence of several layers of regulation involved in OR gene
suppression.31, 1009–1017, November 30, 2007 ª2007 Elsevier Inc. 1009
Figure 1. Strategies Used to Investigate
OR Expression
(A) Transgenic lines were generated using
OMP and Gg8 promoters directly upstream of
three different OR coding sequences. Surpris-
ingly, none of these 31 lines expressed detect-
able transgenic mRNA in the MOE.
(B) In an alternative approach, OR expression
in OSNs was driven indirectly from olfactory
promoters using a tetracycline-transactivator-
based system. We generated transgenic lines
where the Gg8 promoter drives expression of
TTA in immature OSNs (1) and used two
knockin lines: one driving TTA under the con-
trol of the OMP promoter in most mature
OSNs (2) and the other designed to express
rTTA in a subset of mature OSNs that also ex-
press the P2 receptor (3). These tetracycline-
transactivator lines were crossed with multiple
lines of TetO-ORmice (4) to express transgenic
OR and bicistronically encodedGFP (or lacZ) in
OSNs.RESULTS
Receptor-Promoter Interactions Limit OR
Expression
We have been interested in mechanisms governing OR
gene expression and initially explored the use of broadly
expressed OSN genes as a potential tactic to target ex-
pression of one olfactory receptor to many sensory neu-
rons. Surprisingly, placing the OR-coding sequence of
several different ORs under the control of two different
promoters, olfactory marker protein (OMP) and Gg8, that
efficiently drive expression of non-OR reporter genes in
the olfactory system never resulted in transgenic OR ex-
pression in OSNs (Figure 1A). These two promoters were
chosen because they are active at different developmen-
tal stages of the OSN life cycle. OMP is a marker for
mature olfactory sensory neurons (Rogers et al., 1987),
whereas Gg8, a heterotrimeric G protein subunit, is ex-
pressed predominantly in immature OSNs, including
some without dendritic or axonal projections (Ryba and
Tirindelli, 1995). Importantly, such immature neurons do
not express detectable levels of ORs (Cheng and Reed,
2007), and thus the observed suppression of Gg8-OR
transgenes is independent of expression of endogenous
ORs.
How does the inhibition of an OR transgene expression
work, and could it also be part of the normal process con-
trolling endogenous OR expression? We reasoned that
perhaps the proximity of an OR-coding sequence to con-
served elements of a general olfactory promoter (i.e.,
present in the OMP and Gg8 genes) (Wang and Reed,1010 Cell 131, 1009–1017, November 30, 2007 ª2007 Elsevier1993) might provide a signal for transgene silencing.
Therefore, we developed an alternative strategy whereby
OR-coding sequences were placed downstream of a syn-
thetic TetO promoter and crossed these transgenes into
animals expressing tetracycline transactivators (TTA) to
induce OR expression in the MOE (see Figure 1B). To
help track OR-transgene expression, we generated mice
carrying bicistronic constructs consisting of TetO-OR-
IRES-GFP or TetO-OR-IRES-lacZ using a number of dif-
ferent ORs (e.g., M72, M71, P2, P3, MOR28, and rat I7
and I9).
In one set of studies, we made use of OMP-IRES-TTA
knockin mice (OMP-TTA) (Yu et al., 2004) to express
TTA in all mature olfactory neurons. We have now exam-
ined 37 different TetO-OR transgenic lines crossed into
this background and, in 36 of these lines, observed broad
but still limited expression of the transgenes in the MOE
(Figures 2A–2D). Transgene expression was restricted to
only 10%–30% of OSNs (Figures 2A–2D) with substantial
variation in total number of transgene-expressing neurons
between different individual mice of the same genotype.
Thus, separating the olfactory promoter from the OR-
coding sequence can partially overcome the suppression
of OR transgene expression. However, the number and
distribution of OSNs expressing the TetO-OR transgenes
still did not approach the extent and uniformity that
we observed for OMP-GFP (Potter et al., 2001) (see
Figure 2E). To explore this issue further, we examined
the expression of TetO-OR transgenes in the vomeronasal
organ (VNO), which also expresses OMP. Remarkably, the
vast majority of the VNO sensory neurons expressInc.
Figure 2. TetO-OR Transgenes Driven by
OMP-TTA Are Broadly Expressed in the
MOE
(A–G) Three-week-old mice carrying the OMP-
TTA knockin express TetO-OR-IRES-GFP
transgenes but only in subsets of sensory neu-
rons of the MOE (A–D). GFP fluorescence (A–D
and G) and immunohistochemistry (D) demon-
strate expression of a TetO-M72 (A and G),
TetO-rI7 (B), and two TetO-MOR28 lines (C
and D) in 10%–30% of OSNs; note that as ex-
pected the cells expressing GFP are immuno-
reactive for the coexpressed transgenic OR
(D).OMP is expressed in amuch larger number
of OSNs as indicated by anOMP-GFP knockin
(E). In contrast to their limited expression in the
MOEmost TetO-OR transgenes are expressed
in the majority of VNO sensory neurons (with five of six lines showing expression in >80% of neurons) as indicated for a TetO-M72 line (F). Expression
of transgenic and endogenous ORs are mutually exclusive in OSNs (G), as indicated by the lack of cellular overlap between GFP fluorescence (TetO-
M72, green) and endogenous MOR28 (immunofluorescence, red). Scale bars, 20 mm (MOE), 100 mm (VNO).the TetO-OR transgenes (Figure 2F), closelymimicking the
native expression of OMP. Thus, TetO-OR-transgenes are
selectively silenced in the majority of OSNs.
Reciprocal Silencing of Transgenic
and Endogenous Olfactory Receptors
Normally, an OSN only expresses a single olfactory recep-
tor (Chess et al., 1994; Malnic et al., 1999). Therefore, we
wondered whether endogenous OR genes could be ex-
pressed in those cells where the OMP-driven OR trans-
gene is on. To address this issue, we used double-labeling
techniques to determine whether endogenous and trans-
genic ORs are coexpressed. We followed transgene ex-
pression usingGFP fluorescence and carried out immuno-
histochemistry to examine expression of MOR28, an OR
that is expressed in a particularly large subset of OSNs
(10% of OSNs in the ventral MOE) (Tsuboi et al., 1999;
Serizawa et al., 2000; Barnea et al., 2004). Figure 2G dem-
onstrates that transgenic OR-positive neurons never co-
express the endogenous receptor MOR28, and con-
versely OSNs that express MOR28 do not express the
transgene. Thus, expression of transgenic ORs driven by
TTA indirectly from the OMP promoter is sufficient to pre-
vent endogenous OR gene expression. Perhaps more re-
markably, these data also imply that expression of endog-
enous ORs can prevent expression of TTA-driven OR
transgenes. Since the TetO-OR transgenes consist of
just the OR coding sequence linked to a synthetic expres-
sion cassette, such two-way suppression would require
that the highly variable OR-coding sequences (Buck and
Axel, 1991; Zhang et al., 2007) contain elements that are
sufficient on the one hand to be silenced, and on the other,
to silence endogenous OR expression.
If endogenous receptor expression provides the signals
necessary to silence expression of the OMP-driven OR
transgene, how does the transgene ever escape such
suppression? We reasoned that stochastic differences in
the timing of endogenous OR and OMP gene expression
might allow transgenic OR expression to precede accu-Cell 1mulation of endogenous receptor protein in a subset of
OSNs. Thus, we hypothesized that precocious expression
of TTA early in OSN development should increase the
number of transgene-expressing cells, while delayed ex-
pression should further restrict the population of cells
containing transgenic OR.
To test this hypothesis, we crossed our TetO-OR trans-
genes into backgrounds expressing TTA under the control
of promoters that target TTA expression to populations of
olfactory neurons at different developmental stages. To
restrict TTA expression to OSNs already expressing an
endogenous OR, wemade use of mice expressing a bicis-
tronic P2-IRES-rTTA allele (P2-rTTA) (Gogos et al., 2000).
In these animals, the rTTA is encoded by the same tran-
script as the endogenously expressed olfactory receptor
P2, thus ensuring their coexpression. Mice carrying the
P2-rTTA knockin and TetO-OR transgenes were weaned
at 3 weeks of age, and rTTA activity was induced by feed-
ing animals a high-concentration doxycycline diet for an
additional 3 weeks. In situ hybridization confirmed expres-
sion of rTTA in a P2-like pattern (Figure 3A). However,
these same animals had only an extremely small number
of transgenic OR-positive cells. Counts from 4 different
mice totaled just 7, 10, 12, and 64 reporter-positive cells
in the whole MOE, corresponding with expression of the
TetO-OR-IRES-GFP transgenes in less than 2% of the
P2-IRES-rTTA-positive OSNs. Interestingly, the few cells
expressing the OR transgene were all found at the base
of the olfactory epithelium, right at the site where imma-
ture OSNs are located (Figure 3B). Together, these data
demonstrate that the TetO-OR transgenes are silenced
in the vast majority of cells expressing endogenous recep-
tor but suggest that there is a period early in the
development of the OSN where both endogenous (i.e.,
P2-IRES-rTTA) and transgenic receptor (TetO-OR-IRES-
GFP) mRNA can be coexpressed. Presumably, this re-
flects the time required to accumulate sufficient recep-
tor-protein expression to enable the presence of one OR
to silence other OR genes.31, 1009–1017, November 30, 2007 ª2007 Elsevier Inc. 1011
To explore whether there is a permissive time window
for transgenic OR expression that precedes endogenous
OR expression, we carried out the complementary exper-
iment, whereby TetO-OR transgenes are now expressed
in immature OSNs. We achieved this by generating trans-
genic mice where the Gg8 promoter drives expression of
the tetracycline transactivator. Gg8 is robustly expressed
in OSNs of young animals, but as animals age, Gg8 ex-
pression is limited to the regenerating olfactory neural
population (Ryba and Tirindelli, 1995). Three independent
Gg8-TTA lines were generated, and two of these ex-
pressed TTA in at least 50% of the Gg8-positive OSNs
(compare Figures 4A and 4B). The Gg8-TTA mice were
crossed with the various TetO-OR transgenic animals to
determine whether the OR transgenes could be broadly
expressed and not subjected to suppression as seen
when driven by the late-expressing drivers. Indeed, Fig-
ure 4 demonstrates that the OR transgenes are now
broadly expressed. Therefore, it appears that precocious
OR transgene expression does overcome the endoge-
nous OR-dependent suppression observed in OMP-TTA
and P2-rTTA animals.
Are the Gg8-driven ORs functional and capable of sup-
pressing endogenous receptor expression? To test for
function we relied on expression of two receptors, rI7
and M72, whose activating ligands (octanal and aceto-
phenone, respectively) have been identified (Zhao et al.,
1998; Bozza et al., 2002). Figure 4E shows that transgenic
rI7-expressing neurons respond to octanal but not aceto-
phenone, while M72-positive OSNs respond to acetophe-
none but not octanal. To examine the suppressing poten-
tial of these transgenic ORs, we investigated whether
endogenous MOR28 or P2 (using a P2-IRES-tau-lacZ
reporter animal) (Mombaerts et al., 1996) are ever
coexpressed with Gg8-TTA-driven OR transgenes.
Figure 4G demonstrates that transgenic OR-positive cells
never coexpress endogenous MOR28. In addition, we
Figure 3. Suppression of TetO-OR Transgenes in Cells
Expressing Endogenous ORs
(A and B) In situ hybridization using an rTTA probe demonstrates that
6-week-oldmice carrying the P2-rTTA knockin and TetO-rI7 transgene
express rTTA in an OR-like pattern after doxycycline treatment (A). In
contrast, GFP fluorescence revealed that very few, basally localized
OSNs express the TetO-rI7 transgene (B, see text for more detail).
Broken lines indicate the base of the MOE; scale bars, 200 mm (A),
10 mm (B).1012 Cell 131, 1009–1017, November 30, 2007 ª2007 Elsevierhave examined several thousand-P2-positive cells (Fig-
ure 4F) from more than 30 mice and have never observed
even a single P2-positive OSN that coexpresses the
transgene.
Generation of Mice Expressing a Single OR
in the Majority of OSNs
We have shown that by separating the olfactory promoter
from the OR-coding sequence and expressing the OR
precociously using theGg8 promoter, we could overcome
suppression of OR transgenes in OSNs. However, be-
cause Gg8 is predominantly active in developing rather
than mature OSNs, the expression of transgenic ORs indi-
rectly under its control is transient, and by 6 weeks of age,
OR transgene expression is limited to the small population
of regenerating neurons (Figure 5A). We reasoned that if
indeed the first OR that is expressed establishes the cell
identity and inhibits expression of other ORs, then mice
carrying bothGg8-TTA andOMP-TTA should ensure acti-
vation and continued expression of the transgenic OR
throughout the life of an OSN. This approach should result
in transgene expression in a much larger population of
mature OSNs than we observed with the OMP-TTA driver
alone (Figure 5B) and, in principle, should also completely
prevent endogenous OR expression. Indeed, 6-week-old
mice carrying both OMP-TTA and Gg8-TTA now express
TTA-driven transgenic ORs in almost all OSNs (Figures 5C
and 5D). Moreover, as predicted, OSNs expressing the
transgenic receptor do not coexpress endogenous ORs
(MOR28 and P2), which are now restricted to an extremely
small population of OSNs (Figure 5E and data not shown).
Together, these results provide a strong validation of our
proposal that the first OR to be expressed silences other
ORs. In addition, we have shown that by initiating OR ex-
pression in immature OSNs and maintaining it in mature
neurons, it is now possible to drive expression of any
TetO-OR transgene in essentially all OSNs.
Olfactory Receptor Sequence but Not Function
Is Required for OR Silencing
Next, we sought to determine whether nonodorant recep-
tor GPCR transgenes are also subject to OR-dependent
feedback inhibition in OSNs or if this is a property of func-
tional ORs. First, we crossed OMP-TTA mice with either
TetO-hT2R16 (a human taste receptor GPCR) (Mueller
et al., 2005) or TetO-RASSL (a modified opioid receptor)
(Redfern et al., 2000) and observed that these GPCRs
are expressed in the vast majority of OMP-expressing
OSNs (data not shown) demonstrating that the OSN sup-
pression of ORs is not extended toGPCRs in general but is
highly selective for ORs. Is a functional OR required to
suppress the expression of other OR transcripts? To in-
vestigate this, we generated odorant receptors containing
a mutation at the highly conserved DRY sequence, a motif
located at the cytoplasmic face of helix 3 and essential for
activating G proteins and downstream signaling pathways
(Acharya and Karnik, 1996). Notably, our data showed that
the expression of a mutated TetO-M72ALE transgene,Inc.
Figure 4. Precocious Expression of
TetO-OR Using Gg8-TTA Overcomes
Suppression of the TetO-Transgene
(A–E) In situ hybridization of theMOE of 1- to 2-
week-oldmicewithGg8 (A) and TTA (B) probes
indicate that TTA is expressed in a large subset
(>50%) of Gg8-positive neurons in Gg8-TTA
animals. GFP fluorescence demonstrates that
in 2- to 3-week-old double transgenic mice
(carrying Gg8-TTA and TetO-OR transgenes)
many OSNs express TetO-M72 (C) and TetO-
rI7 (D). GFP-positive OSNs (C and D) extend
dendrites to the surface of the MOE with the
more apically located neurons coexpressing
OMP (red immunofluorescence; D). Electro-
physiological recordings from OSNs express-
ing theM72 transgene or rI7 transgene of 1- to
2-week-old mice (E) demonstrate that trans-
genic receptors are functional and confer se-
lective responses to acetophenone (ACE-
M72, n = 24 cells) and octanal (OCT-rI7, n = 7
cells). Arrowheads mark onset of odor pulses
that selectively induced rapid depolarization
of OSNs triggering trains of action potentials
(inset).
(F) Representative confocal images of theMOE
from 3-week-old mice carrying both Gg8-TTA
and TetO-OR transgenes as well as a P2-lacZ
knockin construct to mark cells expressing
the endogenous P2 receptor show that cells
expressing transgenic ORs (GFP fluorescence)
do not coexpress the endogenous receptor P2
(red, b-galactosidase immunofluorescence).
Similarly, there was no overlap between trans-
genic (green, GFP) and the endogenous OR,
MOR28 (red; immunofluorescence) in Gg8-
TTA, TetO-M72 double-transgenic animals
(G). Note that the different levels of GFP-fluo-
rescence reflect regional differences in Gg8-
TTA expression, with higher expression in dor-
sal regions (F; left panel) compared to ventral
regions where MOR28 is predominantly ex-
pressed (G). Scale bar, 20 mm.where DRY has been changed to ALE (Figure 6B), is indis-
tinguishable from that of the fully functional TetO-OR allele
(Figures 2 and 4). Indeed, expression of the M72ALE
transgene both suppresses and is suppressible by endog-
enous ORs (Figure 6B). Independent experiments by Imai
et al. (2006) using a different mutation of the DRY se-
quence are consistent with our data and also indicate
that mutated ORs suppress activation of other endoge-
nous OR genes.
Expression of Multiple Functional Olfactory
Receptors in an OSN
The expression of a single OR in a mammalian OSN in-
volves a number of layers of regulation (e.g., selection,
promoter-dependent inhibition andOR-dependent silenc-
ing) that combine to prevent multiple different OR genes
from being coexpressed. Can such a complex system
be overridden to allow expression of multiple functional
ORs within a single OSN? To address this issue we soughtCell 1to express M72 and rI7 (two receptors that are known to
respond to different odorants; see Figure 4E) in a single
neuron. Thus, we could use electrophysiological record-
ings to unequivocally determine whether a given OSN
did indeed express two functional ORs. Our approach in-
volved generating mice carrying a single construct ex-
pressing these two ORs from the same regulatory se-
quence, TetO-M72-IRES-rI7-IRES-GFP (TetO-M72-rI7;
see Figure 6C). When TetO-M72-rI7 was crossed to
OMP-TTA (or Gg8-TTA), the transgene was expressed in
a subset of OSNs (just like other TetO-OR transgenes)
that now contained mRNA for both transgenic receptors
(e.g., see Figure 6D). More importantly, single-cell record-
ings demonstrated that GFP-labeled neurons responded
robustly both to octanal and acetophenone (Figure 6E).
Thus, while mammalian OSNs are tightly regulated to tran-
scribe only a single OR allele, they are quite capable of
translating, processing, and utilizing two different odorant
receptors.31, 1009–1017, November 30, 2007 ª2007 Elsevier Inc. 1013
Figure 5. Expression of Transgenic Receptor in Most OSNs
(A–E) MOE from a 6-week-oldGg8-TTA, TetO-M72 double-transgenic animal showing transgene expression (GFP; green) in significantly fewer OSNs
than in younger mice (see Figure 4). Note these GFP-positive cells show a markedly basal localization that corresponds with Gg8 expression in im-
mature OSNs. However, the expression pattern of TetO-M72 driven byOMP-TTA in 6-week-old mice (B) remains similar to that observed in 3-week-
old animals (Figure 2), i.e., restricted to 10%–30% of OSNs. Remarkably, in combination Gg8-TTA and OMP-TTA are capable of driving TetO-OR
transgene expression in virtually all OSNs as shown for 6-week old mice expressing TetO-M72 (C and E) and TetO-rI7 (D). Such mice retain
a very small number of OSNs expressing endogenous receptors as indicated by staining for a P2-lacZ reporter (red; E). Dotted lines indicate the
base of the MOE; scale bar, 20 mm (A–E).
(F) Diagram summarizing these results depicts expression of endogenous receptors (red) and TetO-OR transgenes driven byGg8-TTA and/or OMP-
TTA (green) in nonoverlapping subsets of OSNs. When TTA expression is driven byGg8 (left lane), only a small subset of relatively immature neurons
express the OR transgene reflecting the limited expression ofGg8 in 6-week-oldmice. Indirect expression of OR transgenes usingOMP-TTA (middle)
results in endogenous receptor-mediated silencing of the OR transgene in the majority of OSNs. In contrast, by combining OMP-TTA and Gg8-TTA
(right lane), precocious expression of the transgene under the control of Gg8-TTA is maintained in mature neurons under the control of OMP-TTA
silencing expression of endogenous ORs in the vast majority of OSNs.DISCUSSION
A mammalian olfactory neuron expresses a single olfac-
tory receptor, yet it has over 2500 potential OR alleles to
choose from. How this process is orchestrated is a central
question in cellular and molecular neurobiology. Recent
studies in mice have uncovered two important features
of OR gene control. First, a conserved DNA sequence up-
stream of the MOR28 gene, the H element, has been
shown to work in cis to activate any one (but only one at
a time) of a handful of downstream OR genes (Serizawa
et al., 2000, 2003; Fuss et al., 2007). Remarkably, in the
nucleus of an OSN, this same element associates in
a chromosomal complex with the actively expressed OR
allele, even if the OR is from a different genomic location.
These results led Lomvardas and coworkers to propose
that the H elements may also act in trans to select the ex-
pression of a single OR per neuron (Lomvardas et al.,
2006). Second, several studies examined the expression
of OR pseudogenes with various mutations that all pre-
vented translation of a full length odorant receptor (Seri-
zawa et al., 2003; Lewcock and Reed, 2004; Feinstein
et al., 2004). Notably, this type of OR pseudogene was of-
ten coexpressed with a functional OR gene in an OSN.
Complementary experiments that directly examined the1014 Cell 131, 1009–1017, November 30, 2007 ª2007 Elsevierstability of receptor choice demonstrated that OR switch-
ing normally occurs, albeit at a low frequency in immature
OSNs, but is dramatically enhanced whenever an OSN se-
lects a nontranslatable OR mutant (Shykind et al., 2004).
Thus, it was suggested (Serizawa et al., 2003; Lewcock
and Reed, 2004; Shykind et al., 2004) that the odorant re-
ceptor protein is required to initiate a regulatory feedback
process that ensures each OSN expresses a single func-
tional OR allele rather than an OR pseudogene (a signifi-
cant problem for mice and humans, where approximately
20% and 70% of OR genes are nonfunctional) (Zhang
et al., 2007).
In this study, we sought to examine the regulatory hier-
archy of OR gene expression by experimentally dissociat-
ing the process of gene selection from feedback inhibition.
By using heterologous promoters to express transgenic
ORs in the MOE, we demonstrated that although an
OSN can be forced to functionally express two different
ORs, multiple layers of control operate to ensure that
normally just one OR is expressed in each olfactory
neuron.
Together, our results revealed several layers of regula-
tion in the hierarchy that controls odorant receptor choice.
First, we showed that transgenic ORs driven from a syn-
thetic TetO promoter are capable of suppressing selectionInc.
Figure 6. GPCR Function Is Not Re-
quired for OR Suppression, and OSNs
Are Competent to Express Two Func-
tional Receptors
(A–E) Diagram indicates that mutation of the
highly conserved DRY sequence of M72 to
ALE (red residues) prevents G protein coupling
(Acharya and Karnik, 1996). However, this mu-
tation has no influence on the mutually exclu-
sive expression of the transgenic (TetO-
M72ALE) and endogenous receptors driven by
OMP-TTA (B; left panel) or Gg8-TTA (B; right
panel). Shown are TetO-M72ALE expression
(green) with endogenous MOR28 immunofluo-
rescence (B; left panel, red) and b-galactosi-
dase immunostaining in 3-week-old mice also
carrying a P2-lacZ allele (B; right panel, red).
The transgene used to coexpress two odorant
receptors in an OSN is schematically shown
(C). In situ hybridization and GFP fluorescence
(D) indicate that both ORs (M72 and rI7) and
GFP are expressed in the MOE of 3-week-old
mice when driven by OMP-TTA. Moreover,
functional recordings (E) from GFP-labeled
OSNs (1- to 2-week-old animals) demonstrate
that these neurons coexpress M72 and rI7
and respond to both octanal (OCT) and aceto-
phenone (ACE); insets show that both odorants
trigger action potentials (n = 17 cells). Scale
bar, 10 mm (B), 20 mm (D).and/or expression of endogenous OR genes. This finding
is consistent with the OR-mediated feedback inhibition
described previously (Serizawa et al., 2003; Lewcock
and Reed, 2004; Shykind et al., 2004). What signals are
important for this type of suppression? While the mecha-
nisms underlying this process have not been defined, it
was recognized that OR and immunoglobulin gene regula-
tion share features including monoallelic gene expression
and feedback inhibition (Serizawa et al., 2003; Lewcock
and Reed, 2004; Shykind et al., 2004). In the immune sys-
tem, developing B lymphocytes require a functional pre-B
cell receptor that initiates a tyrosine kinase cascade,
which transmits the signal to prevent further gene rear-
rangement and ensures monoallelic expression (Nema-
zee, 2000). Therefore, it was anticipated that signaling
through an odorant receptor might play an important
role in maintaining the monoallelic expression of a func-
tional OR in each OSN (Serizawa et al., 2003; Lewcock
and Reed, 2004; Shykind et al., 2004). Interestingly, our
data demonstrate that suppression of endogenous recep-
tors still occurs even with an OR transgene, TetO-M72ALE,
that contains mutations making it incapable of activating
a G protein pathway (see also Imai et al., 2006). In combi-
nation, these findings imply that although an OSN needs
to be able to detect expression of a full-length OR protein,
signaling through the olfactory signal transduction path-
way is not necessary for the feedback inhibition.Cell 1Second, we demonstrated that while it has not been ex-
perimentally feasible to drive OR expression using general
olfactory promoters in engineered mice, this suppression
can be overcome by separating the promoter from the OR
coding sequence; this is most dramatically illustrated
when comparing Gg8 directly driving an OR transgene
versus Gg8 driving TTA, which in turn drives expression
of a TetO-OR transgene. Third, and perhaps most surpris-
ingly, expression of an endogenous OR prevents expres-
sion of transgenic ORs, even if driven by completely unre-
lated regulatory sequences like those of the bacterial
tetracycline system. Indeed, although TTA is found in the
vast majority of the OSNs in OMP-TTA knockin mice,
TetO-driven ORs are only expressed in a fraction of these
cells. This means that the short (1 kb) and highly variable
OR coding sequences themselves (Buck and Axel, 1991;
Zhang et al., 2007) are sufficient to mark a transgene as
an OR locus and make them one target for feedback inhi-
bition. However, our data do not rule out the existence of
other targets, e.g., at the level of gene selection as recently
postulated (Lomvardas et al., 2006; Serizawa et al., 2006).
Finally, we showed that precocious expression of a trans-
genic OR ensures suppression of endogenous receptors,
thus suggesting a ‘‘first-takes-all/early-bird-gets-the-
worm’’ paradigm.
Mammalian odorant receptors are recognized to have
at least three quite different functions in OSNs: (1)31, 1009–1017, November 30, 2007 ª2007 Elsevier Inc. 1015
determining the odorant selectivity (sensory tuning) of the
neurons (Zhao et al., 1998), (2) playing an instructive role in
targeting their axonal connections in the olfactory bulb
(Ressler et al., 1994; Vassar et al., 1994; Mombaerts
et al., 1996; Wang et al., 1998), and (3) functioning as
the trigger for feedback inhibition (Serizawa et al., 2003;
Lewcock and Reed, 2004; Shykind et al., 2004). Our re-
sults have provided fascinating new insight into the control
of OR gene expression and raise a number of challenging
questions; for example, how does an OSN determine
whether it is expressing an OR gene? What is the nature
of the feedback mechanism that ensures continued ex-
pression of this one OR while keeping all other OR genes
silent even when driven by a synthetic promoter? And
what features of an OR coding sequence does an OSN
recognize to implement this complex regulation? The ap-
proach described here that reliably allows expression of
any receptor throughout the entire epithelium should
help address some of these issues and thereby aid dis-
section of the mechanisms regulating the expression of
OR genes.
EXPERIMENTAL PROCEDURES
Mice
All transgenic lines were produced by pronuclear injection of zygotes
from FVB/N mice. The Gg8-TTA construct consisted of 2561 to +3
(the location of the Gg8 ATG) fused to TTA (Tet-off). TetO-ORs
(TetO-OR-IRES-reporter) utilized full-length OR receptor sequences
in a standard TetO expression vector (Gogos et al., 2000). Three lines
of Gg8-TTA transgenic mice were obtained, all with variation in TTA-
mRNA expression. We selected the line with the highest number of
TTA-positive OSNs where approximately 60%–80% of Gg8-express-
ing cells (variation reflecting mouse-to-mouse differences) are positive
for TTA. Direct Gg8-OR constructs utilized the same Gg8-upstream
sequence; OMP-OR constructs used a previously described promoter
region (Walters et al., 1996). More than 80 independent TetO-OR-
IRES-reporter lines were generated containing ten different OR genes
and either a GFP or lacZ reporter. PCR-mediated mutagenesis was
used to introduce the DRY-to-ALEmutation in both theM72 and rI7 re-
ceptors to generate TetO-M72ALE and TetO-rI7ALE transgenes (both of
which produced equivalent results when expressed in OSNs). For
doxycycline treatment to induce rTTA (Tet-on) activation, mice were
weaned at 3 weeks and were then fed a diet (Bioserv) containing 6
g/kg doxycycline for 3 weeks, at which point olfactory epithelia were
harvested for analysis. Knockin mice: OMP-TTA, P2-rTTA (P2-IRES-
rTTA), OMP-GFP (OMP-IRES-GFP), and P2-lacZ (P2-IRES-Tau-lacZ)
mice have been described previously (Mombaerts et al., 1996; Gogos
et al., 2000; Potter et al., 2001; Bozza et al., 2002) and were generous
gifts from Joseph Gogos and Peter Mombaerts. For all experiments,
the transgenes were hemizygous and knockin backgrounds heterozy-
gous.
Histology and Fluorescence Imaging
In situ hybridization and immunhistochemistry were carried out as de-
scribed previously (Belluscio et al., 2002; Zhao et al., 2003). Antibodies
against b-galactosidase and OMP were from MP Biochemicals and
Wako Chemicals USA, Inc. and were used at 1:500 and 1:5000 dilu-
tions, respectively. Anti-MOR28 antibody was generously provided
by Richard Axel and was used at a 1:6000 dilution (Barnea et al.,
2004). Cy3-labaeled secondary antibodies (used at 1:500 dilutions)
were from Jackson ImmunoResearch. Confocal images (1 mm optical
sections) were collected using a Zeiss LSM-510-Meta confocal (Carl1016 Cell 131, 1009–1017, November 30, 2007 ª2007 Elsevier IZeiss, Inc.). Fluorophores used were GFP (excitation 488, emission
507) and Cy3 (excitation 550, emission 570).
Functional Recordings
Electrophysiological recordings on olfactory sensory neurons were
carried out as described previously (Ma et al., 1999). Briefly, GFP-pos-
itive cells of 2-week-old animals were identified by fluorescence and
DIC optics (Olympus BX51WI), and recordings were targeted to den-
dritic knobs using perforated-patch configuration. Amphotericin B
was included in the patch pipette solution at a final concentration of
240 mg/ml.
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